This year’s TOPRA Summit will provide the chance to hear from regulators about the current state of the International Recognition Framework as a path to accelerate approval of innovative medicines in multiple markets, as they work together to enable faster approvals.
The global agency network – how harmonisation and innovation are paving the way for the future of medicines regulation
When: 23 November 2023
Where: Hilton Canary Wharf Hotel, Marsh Wall, London E14 9SH
Time: 12:30 – 18:30 (GMT) / 13:30 – 19:30 (CET)
Market access leaders will share the key parameters which regulatory affairs professionals should consider for the subsequent rapid access of such medicines. An industry leader will also reveal the key success factors for accelerating approvals, working alongside the regulatory and access stakeholder network, and examine what a ‘good regulatory system’ looks like.
The Summit will be an opportunity to not only hear about the current status of this evolving system for product approval, but also to discuss challenges and opportunities and share ideas about how to evolve the future framework in this multi-stakeholder forum for leading regulatory affairs professionals.
Challenging presentations from experts will help set the scene for further discussions. More information about the sessions will be available soon.
Participants will participate in smaller breakout groups for in-depth discussions and development of proposals for presentation in the Summit whitepaper and sharing with key influencers.
The programme will be available to download soon from here.
Glenn Wells, Chief Partnership Officer, MHRA
Claus Bolte, Chief Medical Officer, SwissMedic
Dan O’Connor, Director, Regulatory Policy & Early Access, APBICPD
This meeting offers 5 CPD hours for successful completion. To learn about why CPD is important, visit our Lifelong Learning page.
- Members: £245+VAT*
- Non-members: £295+VAT*
*VAT, if applicable, is charged at the rate of 20%.